Skip to content

Desflurane Versus Isoflurane for Speeding Postanesthetic Recovery and Hospital Discharge

Desflurane Versus Isoflurane for Speeding Postanesthetic Recovery and Hospital Discharge: a Cluster Randomized Crossover Trial

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06252207
Enrollment
0
Registered
2024-02-09
Start date
2023-12-08
Completion date
2026-03-02
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Brief summary

The investigators thus propose a comparative effectiveness quality improvement project to evaluate the feasibility of switching from near-exclusive use of isoflurane in adult general surgical patients to Desflurane.

Detailed description

The three available volatile anesthetics appear to be comparably safe. However, higher solubility slows emergence from isoflurane and sevoflurane compared to Desflurane. Even a few minutes delay in emergence from anesthesia has financial implications since institutional costs of operating room time can easily be $30 per minute. Postoperative care is also expensive. Furthermore, in busy hospitals such as the Cleveland Clinic, inadequate recovery throughput frequently delays surgery. The investigators thus propose a comparative effectiveness quality improvement project to evaluate the feasibility of switching from near-exclusive use of isoflurane in adult general surgical patients to Desflurane. (The investigators will exclude children because there are compelling clinical reasons to use sevoflurane in pediatric patients.) The proposed comparison is between isoflurane (our current routine) and Desflurane which is no longer used at the Clinic because of price concerns - a decision that that did not consider down-stream effects, including prolonged emergence and recovery.

Interventions

DRUGDesflurane

General anesthesia with desflurlane

DRUGIsoflurane

General anesthesia with isoflurane

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Patients will not be told which type of volatile anesthetic they received.

Intervention model description

Randomized cluster cross-over trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults having general anesthesia in the G operating room suite at the Cleveland Clinic Main Campus.

Exclusion criteria

* Operations lasting \<1.5 hours.

Design outcomes

Primary

MeasureTime frameDescription
Duration of post-anesthesia care unit recovery1 hourTime from entry to the post-anesthesia to discharge from unit.

Secondary

MeasureTime frameDescription
Duration of anesthetic emergence1 hourTime from a MAC fraction of 0.3 (presumably shortly after volatile anesthesia is discontinued) and extubation.
Cost of post-anesthesia care unit.2 hoursCost of post-anesthesia unit care. To be estimated only if there is a substantial difference between the groups.
Delirium5 daysIncidence of postoperative delirium.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAllen Keebler, D.O.

The Cleveland Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026